ATE374366T1 - Aminophenoxyacetamid derivate und diese enthaltende pharmazeutische zusammensetzungen - Google Patents
Aminophenoxyacetamid derivate und diese enthaltende pharmazeutische zusammensetzungenInfo
- Publication number
- ATE374366T1 ATE374366T1 AT01921835T AT01921835T ATE374366T1 AT E374366 T1 ATE374366 T1 AT E374366T1 AT 01921835 T AT01921835 T AT 01921835T AT 01921835 T AT01921835 T AT 01921835T AT E374366 T1 ATE374366 T1 AT E374366T1
- Authority
- AT
- Austria
- Prior art keywords
- sup
- group
- pharmaceutical compositions
- compositions containing
- containing same
- Prior art date
Links
- AHZPJIGLXKMUCO-UHFFFAOYSA-N 2-amino-2-phenoxyacetamide Chemical class NC(=O)C(N)OC1=CC=CC=C1 AHZPJIGLXKMUCO-UHFFFAOYSA-N 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 230000002490 cerebral effect Effects 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000004450 alkenylene group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000112100 | 2000-04-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE374366T1 true ATE374366T1 (de) | 2007-10-15 |
Family
ID=18624324
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01921835T ATE374366T1 (de) | 2000-04-13 | 2001-04-13 | Aminophenoxyacetamid derivate und diese enthaltende pharmazeutische zusammensetzungen |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US7067533B2 (de) |
| EP (1) | EP1228367B1 (de) |
| JP (1) | JP2004501079A (de) |
| KR (1) | KR100853968B1 (de) |
| CN (1) | CN1264821C (de) |
| AT (1) | ATE374366T1 (de) |
| AU (1) | AU784930B2 (de) |
| CA (1) | CA2370487A1 (de) |
| DE (1) | DE60130628T2 (de) |
| ES (1) | ES2291308T3 (de) |
| HU (1) | HUP0203383A3 (de) |
| WO (1) | WO2001079170A2 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE450508T1 (de) * | 2001-09-14 | 2009-12-15 | High Point Pharmaceuticals Llc | Substituierte piperidinen mit selektiver bindungsfähigkeit zu histamin h3-rezeptoren |
| US20030186963A1 (en) | 2001-09-14 | 2003-10-02 | Dorwald Florencio Zaragoza | Substituted piperidines |
| EP1968961A2 (de) | 2005-12-21 | 2008-09-17 | Decode Genetics EHF | Heterocyclische, stickstoffhaltige biarylinhibitoren von lta4h zur behandlung von entzündungen |
| DE102005062990A1 (de) | 2005-12-28 | 2007-07-05 | Grünenthal GmbH | Substituierte Thiazole und ihre Verwendung zur Herstellung von Arzneimitteln |
| CA2683941C (en) | 2007-04-27 | 2014-08-12 | Asubio Pharma Co., Ltd. | Nitrogen-containing six-membered aromatic ring derivatives and pharmaceutical products containing the same |
| WO2017066705A1 (en) * | 2015-10-14 | 2017-04-20 | Aquinnah Pharmaceuticals, Inc. | Compounds, compositions and methods of use against stress granules |
| US20190298705A1 (en) | 2016-06-08 | 2019-10-03 | Glaxosmithkline Intellectual Property Development Limited | Chemical Compounds |
| CN111285820A (zh) * | 2018-12-07 | 2020-06-16 | 成都康弘药业集团股份有限公司 | 一种枸橼酸莫沙必利有关物质及其制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW204411B (de) * | 1991-06-05 | 1993-04-21 | Tokyo Electron Co Ltd | |
| EP0982026B1 (de) | 1998-08-18 | 2006-05-17 | F. Hoffmann-La Roche Ag | Verwendung von Aryl-Cyclohexylamine Derivaten zur Herstellung von NMDA-Rezeptorblockern |
| AU762345B2 (en) * | 1998-10-16 | 2003-06-26 | Asubio Pharma Co., Ltd. | Aminophenoxyacetic acid derivatives as neuroprotectants |
-
2001
- 2001-04-13 HU HU0203383A patent/HUP0203383A3/hu unknown
- 2001-04-13 WO PCT/JP2001/003198 patent/WO2001079170A2/en not_active Ceased
- 2001-04-13 AT AT01921835T patent/ATE374366T1/de not_active IP Right Cessation
- 2001-04-13 JP JP2001576772A patent/JP2004501079A/ja not_active Abandoned
- 2001-04-13 ES ES01921835T patent/ES2291308T3/es not_active Expired - Lifetime
- 2001-04-13 AU AU48762/01A patent/AU784930B2/en not_active Ceased
- 2001-04-13 CN CNB018009085A patent/CN1264821C/zh not_active Expired - Fee Related
- 2001-04-13 EP EP01921835A patent/EP1228367B1/de not_active Expired - Lifetime
- 2001-04-13 CA CA002370487A patent/CA2370487A1/en not_active Abandoned
- 2001-04-13 US US10/009,566 patent/US7067533B2/en not_active Expired - Fee Related
- 2001-04-13 DE DE60130628T patent/DE60130628T2/de not_active Expired - Fee Related
- 2001-04-13 KR KR1020017015979A patent/KR100853968B1/ko not_active Expired - Fee Related
-
2006
- 2006-01-24 US US11/337,664 patent/US20060178401A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN1264821C (zh) | 2006-07-19 |
| EP1228367B1 (de) | 2007-09-26 |
| KR20020016830A (ko) | 2002-03-06 |
| CN1449493A (zh) | 2003-10-15 |
| DE60130628T2 (de) | 2008-07-10 |
| JP2004501079A (ja) | 2004-01-15 |
| US7067533B2 (en) | 2006-06-27 |
| HUP0203383A2 (hu) | 2003-02-28 |
| AU4876201A (en) | 2001-10-30 |
| US20030139447A1 (en) | 2003-07-24 |
| WO2001079170A3 (en) | 2002-06-13 |
| CA2370487A1 (en) | 2001-10-25 |
| ES2291308T3 (es) | 2008-03-01 |
| KR100853968B1 (ko) | 2008-08-25 |
| WO2001079170A2 (en) | 2001-10-25 |
| EP1228367A2 (de) | 2002-08-07 |
| US20060178401A1 (en) | 2006-08-10 |
| DE60130628D1 (de) | 2007-11-08 |
| AU784930B2 (en) | 2006-08-03 |
| HUP0203383A3 (en) | 2003-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0401889A2 (hu) | 1,8-Naftiridin-származékok mint antidiabetikumok és ezeket tartalmazó gyógyszerkészítmények | |
| DK1487829T3 (da) | Thiadizolylpiperazinderivater, der er nyttige til behandling eller forebyggelse af smerte | |
| NZ337118A (en) | 3-piperidyl-4-oxoquinazoline derivatives and pharmaceutical compositions comprising the same useful in treating or preventing arteriosclerotic and/or hyper-lipemia disease, pancreatitis, obesity, hypercholesterolemia and hypertriglyceridemia. | |
| BG107120A (bg) | Нови бавнодействащи бетамиметици, метод за тяхното получаване и приложението им като лекарствени средства | |
| MXPA03011638A (es) | Nuevos derivados de 4-piperazinil indol con afinidad por el receptor 5-ht6. | |
| EA200500174A1 (ru) | Новые производные бензимидазола, полезные в качестве антипролиферативных агентов | |
| HUP0001062A2 (hu) | NAALADáz gátló hatású foszfinsavszármazékokat tartalmazó gyógyászati készítmények | |
| SE0104332D0 (sv) | Therapeutic agents | |
| HUP9603298A2 (hu) | Tachikinin receptor antagonista hatású heterociklusos vegyületek, ezek előállítási eljárása, a vegyületeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| ES2163295T3 (es) | Derivados de imidazol y su uso como inhibidores de la farnesil-protein-transferasa. | |
| CA2401229A1 (en) | Aryl fused azapolycyclic compounds | |
| RO112111B1 (ro) | Compuşi heterobiciclici, procedee pentru prepararea acestora şi compoziţii farmaceutice care îi conţin | |
| BG104853A (en) | Thienylazolylalcoxyethanamines, their preparation and their application as medicaments | |
| AP1816A (en) | 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists. | |
| EA200300071A1 (ru) | Терапевтический препарат для лечения невроза страха (тревоги) или депрессии и производные пиперазина | |
| DE69635857D1 (de) | Pyrrolderivate und medizinische zubereitung. | |
| ATE233754T1 (de) | Diphenyl-piperidin derivate | |
| ATE374366T1 (de) | Aminophenoxyacetamid derivate und diese enthaltende pharmazeutische zusammensetzungen | |
| DE60112725D1 (de) | Phenoxyalkylaminderivate als agonisten des opioid-delta rezeptors | |
| DE69925160D1 (de) | Arylpiperidin- und aryl-1,2,5,6-tetrahydropyridinamid-derivate mit 5ht1a rezeptor aktivität | |
| ATE293591T1 (de) | Neue n-(2-phenyl-3-aminopropyl)naphtamide | |
| ATE315023T1 (de) | Aminoalkylpyrrolidine als serotoninrezeptorliganden sowie diese enthaltende zusammensetzungen, pharmazeutische verwendungen und methoden zu deren synthese | |
| ATE491474T1 (de) | Behandlung von neuropathischen schmerzen mittels eines n-methyl-d-aspartate (nmda)-rezeptor- antagonists | |
| ATE457305T1 (de) | Neue 3-phenylpropionsäurederivate zur behandlung von diabetes | |
| RU2004114262A (ru) | Нейротензии активные производные 2,3-диарилпиразолидина |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |